Stoke Therapeutics Inc (NASDAQ:STOK)
| 7.65 Delayed Data As of Mar 24 |  -0.22 / -2.80%Today’s Change | 6.88 Today|||52-Week Range 24.97 | -17.12% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 1 2018 | Quarter 1 2019 | -- | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | -- | -- | -- |
| Depreciation And Amortization | 32.0K | 80.0K | -- | -- | ||
| Operating Expenses | Gross Income | -32.0K | -80.0K | -- | -- | |
| General Expenses | 1.9M | 6.2M | -- | -- | ||
| Research And Development | 1.2M | 4.1M | -- | -- | ||
| Total Operating Expenses | 1.9M | 6.3M | -- | -- | ||
| Non-Operating Expenses | Operating Income | -1.9M | -6.3M | -- | -- | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -1.9M | -5.7M | -- | -- | |
| Net Income | -1.9M | -5.7M | -- | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 31.3M | 31.3M | -- | -- | |
| Shares To Calculate EPS Diluted | 31.3M | 31.3M | -- | -- | ||
| Earnings Per Share | EPS | -$0.06 | -$0.18 | -- | -- | |
| EPS Diluted | -$0.06 | -$0.18 | -- | -- | ||
